View Cart (0 items)

Pharmaceutical

Lupin recalls 9,000 bottles of antibiotic drug

No Comments
Two lots of Suprax, an antibiotic drug used to treat bacterial infections, are being withdrawn from the U.S. market because the product does not meet federal standards for impurities.
Read More

US, EU generic drug makers call for regulatory cooperation

No Comments
Generic pharmaceuticals manufacturers from Europe and the United States have urged regulators on both sides of the Atlantic to adopt a strategy of "regulatory convergence."
Read More

Scientists find benefits of Tamiflu overestimated

No Comments
A new study raises concerns that the effect of the vastly popular influenza treatment drug may have been overestimated.
Read More

Teva's application for patent extension on Copaxone rejected

No Comments
The U.S. Patent and Trademark Office has rejected the request from Israeli pharma giant Teva Pharmaceuticals to have its patent protection on Copaxone extended until September 2015.
Read More

US demand for pharma excipients to rise 4.3% per year through 2018

No Comments
Excipients in oral formulations, such as tablets and capsules, will be well positioned for strong market performance.
Read More

FDA reviewer slams study that questions generic drug quality

No Comments
A senior official with the U.S. FDA has slammed research that suggests many heart drugs produced outside the U.S. contain impurities.
Read More

Horizon Pharma buys Irish drug maker Vidara

No Comments
Illinois-based Horizon Pharma Inc. announced last week it was taking over Irish Vidara Therapeutics International Ltd. in a reverse merger, moving its headquarters to Dublin.
Read More

Pfizer seeks to ban sales of generic Viagra in US

No Comments
U.S. pharmaceutical corporation Pfizer has filed a lawsuit against Indian drug maker Torrent Pharmaceuticals Ltd. in an effort to prevent sales of a generic version of Viagra.
Read More

Canada's drug spending growth slowed by generics

No Comments
Market share is increasing for generics drugs, which are typically much cheaper than branded and patented drugs.
Read More

Many generic drugs fail to serve their purpose, doctors warn

No Comments
Doctors and researchers have criticized the U.S. Food and Drug Administration (FDA) for failing to control the effectiveness of the vast majority of pharmaceutical products sold in the United States.
Read More